explore
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: Listen: Biogen's messy board & Laronde's data problem
Next article: Listen: Biogen's messy board & Laronde's data problem
leisure time
hotspot
-
Menendez indictment could see pharma lose a key ally
2025-09-14 10:01 -
Sudafed saga points to U.S. issues with evaluating older drugs
2025-09-14 09:32 -
Connecting traumatic brain injury and domestic violence
2025-09-14 09:17 -
Duchenne patients, backed by ‘dark money’ group, to debate drug prices
2025-09-14 09:15 -
These geoengineering technologies could help combat the climate crisis, scientists say
2025-09-14 08:59 -
These geoengineering technologies could help combat the climate crisis, scientists say
2025-09-14 07:56